ST-Segment Depression in Hyperventilation Indicates a False Positive Exercise Test in Patients with Mitral Valve Prolapse by Michaelides, Andreas P. et al.
SAGE-Hindawi Access to Research
Cardiology Research and Practice
Volume 2010, Article ID 541781, 7 pages
doi:10.4061/2010/541781
Clinical Study
ST-Segment Depression in Hyperventilation Indicates a False
Positive Exercise Test in Patients with Mitral Valve Prolapse
AndreasP. Michaelides,1 Charalampos I.Liakos,1 Charalambos Antoniades,1
DimitriosL.Tsiachris,1 DimitriosSoulis,1 Polichronis E. Dilaveris,1
Konstantinos P.Tsiouﬁs,2 and Christodoulos I. Stefanadis2
1Exercise Laboratory, 1st University Department of Cardiology, Athens Medical School, Hippokration Hospital, 15772 Athens, Greece
2Catheterization Laboratory, 1st University Department of Cardiology, Athens Medical School,
Hippokration Hospital, 15772 Athens, Greece
Correspondence should be addressed to Charalampos I. Liakos, bliakos@med.uoa.gr
Received 26 July 2010; Revised 15 October 2010; Accepted 16 October 2010
Academic Editor: Gavin W. Lambert
Copyright © 2010 Andreas P. Michaelides et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objectives. Mitral valve prolapse (MVP) is a known cause for false positive exercise test (ET). The purpose of this study was to
establish additional electrocardiographic criteria to distinguish the false positive exercise results in patients with MVP. Methods.
We studied 218 consecutive patients (53 ± 6 years, 103 males) with MVP (according to echocardiographic study), and positive
treadmill ET was performed due to multiple cardiovascular risk factors or angina-like symptoms. A coronary angiography was
performed to detect coronary artery disease (CAD). Results. From 218 patients, 90 (group A) presented with normal coronary
arteries according to the angiography (false positive ET) while the rest 128 (group B) presented with CAD. ST-segment depression
in hyperventilation phase was present in 54 patients of group A (60%) while only in 14 patients of group B (11%), P<. 05.
Conclusions. Presence of ST-segment depression in hyperventilation phase favors a false positive ET in patients with MVP.
1.Introduction
Mitral valve prolapse (MVP) is one of the most prevalent
cardiac valvular abnormalities. Using standardized echocar-
diographic diagnostic criteria, a community-based study
showed that MVP occurs in 2.4 percent of the population
[1, 2]. It is twice as frequent in females as in males. The
clinical and echocardiographic criteria for the diagnosis of
MVP have been well established. The characteristic systolic
click and mid-to-late systolic murmur is a major diagnostic
criterion. The most speciﬁc echocardiographic criterion is
superior displacement of one or both mitral valve leaﬂets by
more than 2mm above the plane of the annulus [2, 3] in the
long axis.
The vast majority of patients with MVP are asymp-
tomatic and remain so throughout their lives. However,
some patients may complain of symptoms like syncope, pre-
syncope, palpitations, chest discomfort, and, when mitral
regurgitation (MR) is severe, symptoms of diminished
cardiac reserve. Chest discomfort may be typical of angina
pectoris but is more often atypical in that it is prolonged, not
clearly related to exertion, and punctuated by brief attacks or
severe stabbing pain at the apex.
Inthesepatientsfalsepositiveexercisestressresponses,as
testiﬁed by coronary angiography, electrocardiographic [4–
14] as well as with thallium perfusion imaging [12, 15, 16]
both have been consistently reported in several studies.
Since the diagnosis of coronary artery disease (CAD)
in patients with MVP based on the standard ST-segment
depression criteria during exercise testing (ET) is uncertain,
the establishment of accessional electrocardiographic (ECG)
criteria for the discrimination of true positive exercise
responses would be of great value.
It is well known that patients with MVP often have
high levels of catecholamines [17–22]. On the other hand,
patientswithhighlevelsofcatecholaminesfrequentlypresent
with ST-segment depression during hyperventilation in
the absence of CAD [23–27]. We examined whether the2 Cardiology Research and Practice
presence of ST-segment depression during hyperventilation
in patients with MVP leads to false positive ETs.
2.MaterialsandMethods
2.1. Study Population. From 2006 to 2009, 218 consecutive
patients with MVP (103 males, 58 ± 8y e a r s )a n dan o r m a l
resting ECG who presented with ischemic ECG changes
duringETandagreedtoundergocoronaryangiographywere
included in the study. During the recruitment period, a total
of 746 patients with MVP were examined. From them, 252
(34%) presented with ischemic ECG changes during ET in
our laboratory, and 218 (87%) accepted to participate in our
study.
The diagnosis of MVP was based on an echocardio-
graphic study while the deﬁnition of ischemic ECG response
during ET was based on the standard ST-segment deviation
criteria. Treadmill ET was performed in these patients
due to multiple cardiovascular risk factors or angina-like
symptoms.
PatientswithknownhistoryofCAD,leftorrightbundle-
branch block, left or right ventricular hypertrophy, other
valvular abnormality, pre-excitation syndromes, and those
who were receiving digitalis or were unable to walk on
treadmill were excluded from the study.
All medications were discontinued for at least 5 half-lives
before the ET.
The study was approved by our hospital’s committee on
human research, and written informed consent was obtained
from all participants.
2.2. Echocardiographic Study. Echocardiographic study was
performed to all patients in order to establish the diagnosis
of MVP [16]. The two-dimensional echocardiogram showed
that one or both mitral valve leaﬂets billow by at least 2mm
into the left atrium during systole in the long-axis view
[3, 28, 29]. Thickening of the involved leaﬂet to greater
than 5mm was often observed supporting the diagnosis.
Findings like increased leaﬂet area, leaﬂet redundancy,
chordal elongation, and annular dilation were indicative of
more severe myxomatous disease.
From218patientswithdocumentedprolapse,180(83%)
had typical auscultatory ﬁndings (click or murmur).
Doppler echocardiography frequently revealed mild MR
that was not always associated with an audible murmur.
Moderate to severe MR was present in about two-thirds of
patients with posterior leaﬂet prolapse and in about one-
fourth of patients with anterior leaﬂet prolapse which is in
concordance with the literature [30].
2.3. Treadmill ET—Hyperventilation. All patients performed
ET on a Marquette case system (GE-Medical System, Mil-
waukee, WI), according to the multistage Bruce protocol.
Each patient had an electrocardiogram (ECG) recorded
with the standard 12 leads. The ECG was recorded con-
tinuously at the resting status (both supine and standing),
during hyperventilation, during exercise, and for up to the
10th minute of the recovery period. Blood pressure was
measured every minute at the resting status (both supine
and standing), during hyperventilation, during exercise, and
during the recovery period, with a sphygmomanometer.
Exercise was terminated in the presence of exercise-
limiting angina, fatigue, dyspnea, ataxia, dizziness, near
syncope, or signs of poor perfusion (cyanosis or pallor).
In the absence of symptoms, the test was terminated
at the occurrence of ≥0.2mV ST-segment depression or
≥0.1mV ST-segment elevation, an exaggerated blood pres-
sure response (≥250/115mm Hg), a decrease in systolic
blood pressure ≥10mm Hg from baseline or speciﬁc
arrhythmias (sustained ventricular tachycardia, multifocal
ventricular premature beats, ventricular triplets, supraven-
tricular tachycardia, heart block, or bradyarrhythmia) [31].
All patients underwent forced hyperventilation (breaths
asdeepandrapidaspossible—atleast30breaths/min)inthe
standing position before the exercise. The test required the
subject to overbreadth voluntarily the room air (FiO2: 21%)
withafrequencyrateof40–45breaths/minatroomtempera-
ture (20–22◦C). The target ventilation rate was equivalent to
the maximum voluntary ventilation, and the mean duration
of the test was 1 minute. Hyperventilation was discontinued
earlierifthepatientfeltdizziness,lightheadedness,weakness,
shortness of breath, a sense of unsteadiness, tingling around
the mouth, ﬁngertips, and toes (as a result of hypocapnia) in
order to avoid loss of consciousness.
The interpretation of exercise testing included symp-
tomatic response, exercise duration, blood pressure, heart
rate, and ECG response.
An ischemic ST-segment response during exercise and
recovery was deﬁned (according to the standard ST-segment
deviation criteria) as horizontal or downsloping depression
of ≥0.1mV below the resting ST-segment level (measured
60 milliseconds after the J-point), upsloping depression
of ≥0.15mV (measured 80 milliseconds after J-point), or
elevation of ≥0.1mV [31].
Intensive care was taken to detect ST-segment depression
in any of the leads during the hyperventilation phase of the
test since all patients presented with normal baseline (both
supine and standing) ECG. In the presence of ST-segment
depression during hyperventilation, an ischemic ST-segment
response during exercise was deﬁned as additional depres-
sion of ≥0.1mV (measured in the standing position) below
the hyperventilation ST-segment level (Figure 1).
Exercise tests without ischemic ST-segment changes,
which were terminated when the heart rate was <85% of the
predicted maximal heart rate, were considered inconclusive.
Patients with inconclusive exercise tests were excluded from
the study.
ECG measurements were performed with a magnifying
lens by two of the investigators who were unaware of the
results of the coronary angiography. The interobserver and
intraobserver variability for ST-segment changes was 0.007±
0.005 and 0.008 ± 0.004mV, respectively. Disagreements
between observers were resolved by a third interpreter.
2.4. Coronary Arteriography. Selective coronary arteriogra-
phy was performed to all patients, using the percutaneousCardiology Research and Practice 3
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Figure 1: Electrocardiographic (ECG) recordings from a 48-year
old woman with mitral valve prolapse undergoing maximal tread-
mill test. A. Resting status-standing position-normal breathing:
normal ECG, B. Resting status-standing position-hyperventilation:
ST-segment depression in leads II, III, aVF (≈0.13mV)/V4,V 5,
V6 (≈0.1mV), C. Peak exercise-standing position: ST-segment
depression in leads II, III, aVF (≈0.23mV)/V4,V 5,V 6 (≈0.16mV).
This was a false positive exercise test since this woman had a normal
coronary arteriography.
(Judkins) technique. The left coronary artery was visualized
atthe60◦ leftanterioroblique,the30◦ rightanterioroblique,
and the left lateral position, with a 30◦ cranial angulation.
The right coronary artery was visualized at the 60◦ left
anterior oblique and the 30◦ right anterior oblique position.
Signiﬁcant coronary stenosis was deﬁned as diameter
narrowing of 70% or more in the lumen of left anterior
descending (LAD), left circumﬂex (LCx), and right coronary
artery (RCA), or 50% or more in the lumen of left main
coronary artery. The interpretation was performed by two
investigators who were unaware of ET results.
2.5. Statistical Analysis. All continuous variables were nor-
mally distributed as conﬁrmed by using Kolmogorov-
Smirnov test and are expressed as mean±SD. Categorical
variables are reported as observed number (percentage).
Comparisons of continuous variables between two groups
were performed by using unpaired t-test. Categorical vari-
ables between two groups were compared using chi-square
test (with the use of Yates correction) or Fisher’s exact t-
test. All tests were two-sided. Diﬀerences were considered as
statistically signiﬁcant for P value <.05. Data analysis was
performed with SPSS 15.0 statistical software (SPSS Inc.,
Chicago, IL, USA).
3. Results
From 218 patients included in the study, 103 (47%) were
males while the rest 115 (53%) patients were females.
Patient’s characteristics, echocardiographic and angio-
graphic data are demonstrated in Table 1.
There were no diﬀerences between males/females regard-
ing the mean age of the patients or the prevalence of arterial
hypertension, diabetes mellitus, hypercholesterolemia, and
smoking.
Anterior leaﬂet prolapse was present in 80 males (78%)
and 77 females (67%), P = .048 while posterior leaﬂet
prolapse was present in 23 males (22%) and 38 females
(33%), P = .042. The ejection fraction of the left ventricle
was similar in men and women.
Normal coronary arteries were found in 38 males (37%)
and 52 females (45%) while 1-vessel disease was found in
33 males (32%) and 37 females (32%), 2-vessel disease in
21 males (20%) and 18 females (16%), and 3-vessel disease
in 11 males (11%) and 8 females (7%), P = NS for all.
Overall, from 218 patients with positive ET, 90 (41%) had
normal coronary angiograms (false positive ETs = 41%).
Coronary vasospasm was not observed in any patient during
angiography.
Exercise and ECG data are presented in Table 2.
Exercise parameters (resting/hyperventilation/maximal
systolic blood pressure, resting/hyperventilation/maximal
heart rate, percentage of exercise-induced angina) were
similar in males and females with the exception of the
duration (in sec) of the exercise (520 ± 32 for males versus
470±25 for females, P = .036). Hyperventilation induced an
increase in systolic blood pressure (8 ±3v e r s u s8±4 mmHg4 Cardiology Research and Practice
Table 1: Patients characteristics, echocardiographic and angiographic data.
Males (n = 103) Females (n = 115) P value
Baseline characteristics
Age 49 ±55 6 ±7N S
Arterial hypertension 7/103 (7%) 11/115 (10%) NS
Diabetes mellitus 5/103 (5%) 7/115 (6%) NS
Hypercholesterolemia 38/103 (37%) 46/115 (40%) NS
Smoking 35/103 (34%) 32/115 (28%) NS
Echocardiographic data
Leaﬂet involved:
(i) anterior 80/103 (78%) 77/115 (67%) .048
(ii) posterior 23/103 (22%) 38/115 (33%) .042
LVEF (%) 53 ±25 5 ±3N S
Angiographic data
Vessels involved:
(i) 0 38/103 (37%) 52/115 (45%) NS
(ii) 1 33/103 (32%) 37/115 (32%) NS
(iii) 2 21/103 (20%) 18/115 (16%) NS
(iv) 3 11/103 (11%) 8/115 (7%) NS
LVEF: Left Ventricle Ejection Fraction, NS: Not Signiﬁcant.
Table 2: Exercise and electrocardiographic parameters.
Males (n = 103) Females (n = 115) P value
Exercise parameters
Exercise duration (sec) 520 ±32 470 ±25 0.036
Resting systolic blood pressure (mmHg) 134 ±12 136 ±13 NS
Systolic blood pressure at hyperventilation (mmHg) 142 ±11 144 ±12 NS
Maximal systolic blood pressure (mmHg) 188 ±16 193 ±15 NS
Resting heart rate (bpm) 80 ±57 8 ±4N S
Heart rate at hyperventilation (bpm) 106 ±6 106 ±5N S
Maximal heart rate (bpm) 162 ±9 169 ±6N S
Exercise-induced Angina 8/103 (8%) 6/115 (5%) NS
Electrocardiographic parameters
Presence of ↓ ST at hyperventilation: 27/103 (26%) 41/115 (36%) .041
(i) inferior leads (II, III, aVF) 12/103 (12%) 19/115 (17%) .045
(ii) anterior leads (V1,V 2,V 3) 0/103 (0%) 2/115 (2%) .038
(iii) lateral leads (V4,V 5,V 6) 5/103 (5%) 7/115 (6%) NS
(iv) inferior + lateral leads (II, III, aVF, V4,V 5,V 6) 10/103 (10%) 13/115 (11%) NS
Maximal ↓ ST at hyperventilation (mV): 0.09 ±0.03 0.11 ±0.05 NS
(i) inferior leads (II, III, aVF) 0.09 ±0.04 0.11 ±0.05 NS
(ii) anterior leads (V1,V 2,V 3)0 .02 ±0.02 0.01 ±0.01 NS
(iii) lateral leads (V4,V 5,V 6)0 .09 ±0.03 0.1 ±0.01 NS
Maximal ↓ ST at peak exercise (mV): 0.15 ±0.02 0.19 ±0.03 NS
(i) inferior leads (II, III, aVF) 0.15 ±0.05 0.19 ±0.03 NS
(ii) anterior leads (V1,V 2,V 3)0 .04 ±0.03 0.01 ±0.01 NS
(ii) lateral leads (V4,V 5,V 6)0 .11 ±0.02 0.18 ±0.01 .041
Time for exercise-induced ↓ ST:0.1 mV (sec) 390 ±16 362 ±12 .043
NS: Not Signiﬁcant.Cardiology Research and Practice 5
for males and females, resp., P = NS) and heart rate (26 ± 4
versus 28 ±4 bpm for males and females, resp., P = NS).
ST-segment depression during the hyperventilation
phase of the test was detected in 27 males (26%) and 41
females (36%), P = .041. From them, 31 patients (46%)
presented with ST-segment depression in the inferior leads
(II, III, aVF), 2 patients (3%) in the anterior leads (V1,V 2,
V3), 12 patients (18%) in the lateral leads (V4,V 5,V 6) while
the rest 23 patients (34%) in both inferior and lateral leads.
Furthermore, 27 patients (40%) presented with horizontal
and the rest 41 patients (60%) with downsloping pattern of
ST-segment depression. This depression was measured (in
mV) up to 0.09 ± 0.03 in men versus 0.11 ± 0.05 in women,
P = NS (0.09 ±0.04 versus 0.11 ±0.05 for the inferior leads,
0.02 ± 0.02 versus 0.01 ± 0.01 for the anterior leads, and
0.09 ± 0.03 versus 0.1 ± 0.01 for the lateral leads in men and
women, resp., P = NS for all).
Maximal exercise-induced ST-segment depression (in
mV) was measured at peak exercise up to 0.15 ±0.02 in men
versus 0.19 ± 0.03 in women, P = NS (0.12 ± 0.05 versus
0.19 ± 0.03 for the inferior leads—P = .044—, 0.04 ± 0.03
versus 0.01 ± 0.01 for the anterior leads—P = NS—and
0.11±0.02versus0.18±0.01forthelateralleads—P = .041—
in men and women, resp.).
Time required for exercise-induced ST-segment depres-
sion of 0.1mV (in sec) was greater in males (390 ± 16 versus
362 ±12, P = .043).
The correlation of ST-segment depression at hyperven-
tilation with angiographic result is presented in Table 3.
Patients with normal coronary arteries appeared with ST-
segmentdepressionduringhyperventilationmorefrequently
versus them with CAD (55% versus 9% for men, 63%
versus 13% for women, 60% versus 11% for total popu-
lation, P<. 05 for all). Overall, from 68 patients with
ST-segment depression during hyperventilation, 54 (79%)
appeared without CAD (Table 3, Figure 1) since from
150 patients without ST-segment depression during hyper-
ventilation, only 36 (24%) appeared without CAD (false
positive ETs=24%). According to these data, sensitivity (Se),
speciﬁcity (Sp), positive prognostic value (Ppv), negative
prognostic value (Npv), and diagnostic accuracy (Ac) of the
absence of ST-segment depression during hyperventilation
in detecting CAD in patients with MVP and positive ET were
calculated (up to 89, 60, 76, 79, and 77%, resp.) and are
presented in Figure 2.
4. Discussion
The prevalence of abnormal exercise tests in patients with
MVP varies in the literature from 10 to 60% [4–14]; the
overall prevalence, however, is in the region of 33% [11].
The results of this study indicate that false positive
exercise response is common in patients with MVP (≈41%)
which is concordant with the literature [4–16].
Hyperventilation-induced ST-segment depression is a
criterion that (according to the results of this study)
makes CAD less likely in MVP patients with exercise-
induced ischaemic response. The incorporation of this new
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Figure 2: Diagnostic ability of a normal electrocardiogram during
hyperventilation in detecting CAD in patients with MVP and
positive ET.
electrocardiographic criterion in the standard ST-segment
depression criteria makes exercise stress testing much more
accurate in detecting CAD in MVP patients. With sensitivity
up to 89% and reduced false positive responses compared
to standard ET (from 41% to 24%), a normal ECG during
hyperventilation makes an ischaemic stress response in
patients with MVP quite trustworthy.
No previous data are available concerning the ability
of ST-segment changes during hyperventilation to detect
coronary artery disease in patients with MVP when accom-
panying with positive exercise-induced responses. Ellestad
et al. report that patients with abnormal autonomic drive
(high levels of catecholamines) have demonstrated ST-
segment depression after hyperventilation as well after
exercise [23]. In their experience, patients who display ST-
segment depression at rest or an increased ST-segment
depression after hyperventilation, in whom the depression
tends to return to normal with exercise, usually do not
have epicardial CAD [23]. Jacobs et al. [24] also report that
changes associated with hyperventilation are usually related
with normal coronary arteries. Propranolol and other beta
blockers have been shown to block the ST-segment changes
associated with hyperventilation, suggesting an autonomic
etiology [25–27].
Mechanismsinvolvingdisturbedbalancebetweenoxygen
demand and supply, decreased level of high-energy phos-
phate stores, changes in electrolyte contents, intracellular
Ca2+ overload, and oxidative stress play essential role in
thepathogenesisofcatecholamine-inducedmyocardialdam-
age [32]. Several studies have shown that under stressful
conditions high concentrations of catecholamines become
oxidized to form aminolutins and generate oxyradicals.
These oxidation products of catecholamines have been
demonstrated to produce coronary spasm, arrhythmias, and
cardiac dysfunction by inducing Ca2+-handling abnormali-
ties in both sarcolemmal and sarcoplasmic reticulum, defects
in energy production by mitochondria, and myocardial cell
damage [32]. Hyperventilation-induced ST-segment depres-
sion, blood pressure, and heart rate increase in patients with6 Cardiology Research and Practice
Table 3: Correlation of ST-segment depression at hyperventilation with angiographic result.
No-CAD (Group A, n = 90) CAD (Group B, n = 128) P value
Patients with ↓ ST at hyperventilation
Males (n = 27) 21/38 (55%) 6/65 (9%) .004
Females (n = 41) 33/52 (63%) 8/63 (13%) .002
Total population (n = 68) 54/90 (60%) 14/128 (11%) .001
Patients without ↓ ST at hyperventilation
Males (n = 76) 17/38 (45%) 59/65 (91%) .004
Females (n = 74) 19/52 (37%) 55/63 (87%) .002
Total population (n = 150) 36/90 (40%) 114/128 (89%) .001
CAD: coronary artery disease.
MVP is probably due to excessive amount of catecholamines,
increased oxygen demand, and coronary spasm [17–22, 33]
and may be prevented by beta-adrenergic blockers, which are
usefulforloweringoxygenconsumptionanddownregulating
sympathetic nervous system activity [27].
Considering all these potential pathophysiological mech-
anisms and that patients with high levels of catecholamines
frequently present with ST-segment depression during
hyperventilation in the absence of CAD [25–27], the
improvement in diagnostic ability of exercise testing in
our study with the use of this novel ECG criterion seems
reasonable.
5. Conclusions
Absence of ST-segment changes during hyperventilation in
MVP patients with positive exercise testing is proved to
be a useful diagnostic tool for detecting CAD with Se,
Sp, Ppv, Npv, and Ac up to 89, 60, 76, 79, and 77%,
respectively. Reducing false positive responses (from 41% to
24%), this novel criterion could guide physicians to avert
unnecessarycoronaryarteriographyinanamountofpatients
with MVP (especially them without angina-like symptoms
during exercise). Since exercise ECG test is a popular,
well-established, inexpensive, widely available procedure, we
should probably consider it as an acceptable diagnostic tool
for CAD even in patients with MVP after incorporating this
novel ECG criterion.
6. Limitations
T h er e s u l t so fo u rs t u d yw o u l db em o r ee x p l i c a b l ei f
catecholamines levels had been measured in our patients.
Besides, it should be clearly stated that unless an MVP
diagnosis is in fact known, the study results do not apply to
other patient groups.
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